Drugs / Xylocain
last change Jul 2020 re-read 3 minutes ago

Xylocain

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy2 trials
Phase 3 NCT01805726 Comparator Feb → Mar 2013 — Saint-Joseph University Completed No outcome recorded
— NCT03871465 Background Aug 2018 → Jul 2020 bursitis, shoulder impingement syndrome Shin Kong Wu Ho-Su Memorial Hospital Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Xylocain “2ml triamcinolone (1ml/10mg) and 3ml 1% xylocain will be injected into the affected SASD bursa under ultrasound guidance.” NCT03871465 ↗
1

NCT01805726 ↗

Route Other “will be injected into the affected SASD bursa” NCT03871465 ↗